Athira Pharma, Inc. (ATHA) Financials

ATHA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 160245 30057
2023-09-30 184.7 million 29.9 million
2023-06-30 208.0 million 23.1 million
2023-03-31 232.8 million 21.6 million

ATHA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -26293 2228
2023-09-30 -24.0 million 2.5 million
2023-06-30 -24.3 million 3.1 million
2023-03-31 -26.4 million 2.8 million

ATHA Net Income

No data available :(

ATHA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 147419 - 1.6 million
2023-09-30 172.9 million - 1.7 million
2023-06-30 186.1 million - 1.8 million
2023-03-31 186.0 million - 1.8 million

ATHA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 38101
2023-09-30 38.1 million
2023-06-30 38.0 million
2023-03-31 37.9 million

ATHA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 23680 6962 -
2023-09-30 30000 27.2 million 7.8 million -
2023-06-30 33000 21.6 million 10.0 million -
2023-03-31 241000 21.3 million 8.5 million -

ATHA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 244000
2023-06-30 - 297000
2023-03-31 - 287000

ATHA

Price: $2.18

52 week price:
1.33
4.30

Earnings Per Share: -3.09 USD

P/E Ratio: -0.98

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 290900

Market Capitalization: 75.5 million

Links: